跳至主要内容
临床试验/NCT03742661
NCT03742661进行中(未招募)不适用

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis

Brain Sentinel2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2018年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
5
试验地点
2
主要终点
Diagnostic Impact Form Questionnaire

研究概览

简要总结

This is an open label, randomized, prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure monitoring and alerting system for Veterans with a history of motor seizures (epileptic, non-epileptic or unknown) with upper extremity motor involvement, presenting with questionable spell characterization, taking place in the home setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is a veteran with a reported history of motor seizures (epileptic, non-epileptic or unknown) with upper extremity motor involvement, presenting with questionable spell characterization.
  • Subjects has failed fewer than 3 anti-epileptic drugs (single or combination).
  • Male or Female between the ages 22 to
  • If female and of childbearing potential, subject must agree to not become pregnant during the trial.
  • Can understand and sign written informed consent or will have a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
  • Subject or Primary Caregiver must be competent to follow all study procedures.
  • Subject must be willing to use the Seizure Monitoring and Alerting System for a prolonged period of time (up to 120 days), for a minimum of 30 hours/ week.

排除标准

  • The subject cannot be pregnant, or nursing.
  • The subject cannot be sensitive or allergic to adhesives or tapes.
  • The subject may not be enrolled in another Clinical Trial.
  • The subject is homeless or in a home without a power supply.

结局指标

主要结局

Diagnostic Impact Form Questionnaire

时间窗: Up to 5 months

The physician will complete this questionnaire after each 30 days of device use to determine if information acquired will change the physician's assessment of the patient's seizures and their treatment plan.

次要结局

  • Personal Impact of Epilepsy Scale (PIES) Survey(5 years)
  • VR-12 Survey(5 years)
  • VA Administrative Data(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验